Medicare Enrolled
Dr. Ahmad El-Far, M.D.
Hematology & Oncology · Winter Haven, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. El-Far from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. El-Far? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. El-Far
Dr. Ahmad El-Far is a hematology & oncology in Winter Haven, FL, with 15 years in practice. Based on federal Medicare data, Dr. El-Far performed 242,699 Medicare services across 5,288 unique beneficiaries.
Between the years covered by Open Payments, Dr. El-Far received a total of $8,369 from 53 pharmaceutical and/or device companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. El-Far is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice▲ Top 2% volume in FL$ $8,369 industry payments
Medicare Practice Summary
Medicare Utilization ↗242,699
Medicare services
Top 2% in FL for hematology & oncology
5,288
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16,180 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 156,000 | $1 | $2 |
| Epoetin alfa injection (Procrit) for anemia | 20,120 | $6 | $21 |
| Iron infusion (Feraheme) | 18,870 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia | 10,480 | $6 | $19 |
| Denosumab injection (Prolia/Xgeva) | 7,140 | $19 | $41 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 4,625 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 4,551 | $0 | $0 |
| Dexamethasone injection (steroid) | 2,555 | $0 | $0 |
| Complete blood count (CBC) with differential | 1,772 | $8 | $16 |
| Blood draw (venipuncture) | 1,767 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,510 | $1 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 1,504 | $0 | $0 |
| Comprehensive metabolic blood panel | 991 | $10 | $21 |
| Drug injection, under skin or into muscle | 841 | $11 | $42 |
| Office visit, established patient (20-29 min) | 763 | $63 | $150 |
| Infusion into a vein for hydration, each additional hour | 706 | $10 | $40 |
| Iron level test | 636 | $6 | $13 |
| Infusion, normal saline solution, 250 cc | 620 | $1 | $1 |
| Ferritin level test (iron stores) | 613 | $13 | $27 |
| Transferrin (iron binding protein) level | 607 | $12 | $26 |
| Office visit, established patient (30-39 min) | 550 | $93 | $218 |
| Lactate dehydrogenase (enzyme) level | 542 | $6 | $12 |
| Uric acid level test | 422 | $4 | $9 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 414 | $16 | $64 |
| Vitamin B-12 level test | 401 | $15 | $30 |
| Folic acid level test | 384 | $14 | $29 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 371 | $22 | $91 |
| Administration of chemotherapy into vein, 1 hour or less | 365 | $98 | $411 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 317 | $48 | $208 |
| Injection, diphenhydramine hcl, up to 50 mg | 298 | $1 | $2 |
| Administration of chemotherapy into vein, each additional hour | 219 | $21 | $89 |
| Carcinoembryonic antigen (cea) protein level | 204 | $19 | $38 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 171 | $54 | $230 |
| Office visit, established patient, complex (40-54 min) | 142 | $132 | $294 |
| Hospital follow-up visit, moderate complexity | 120 | $63 | $148 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 108 | $1 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 89 | $1 | $4 |
| Infusion into a vein for hydration, 31-60 minutes | 76 | $23 | $100 |
| New patient office visit (45-59 min) | 74 | $123 | $333 |
| Administration of additional new drug or substance into vein, 1 hour or less | 72 | $49 | $200 |
| Thyroid stimulating hormone (TSH) test | 66 | $16 | $34 |
| Initial hospital admission, moderate complexity | 57 | $101 | $283 |
| PSA test (prostate cancer screening) | 52 | $18 | $37 |
| Collection of blood sample from implanted device | 45 | $19 | $72 |
| Ct scan of chest before and after contrast | 40 | $107 | $680 |
| Hospital follow-up visit, high complexity | 39 | $94 | $213 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 38 | $24 | $93 |
| Blood creatinine level | 37 | $5 | $10 |
| Urea nitrogen level to assess kidney function, quantitative | 37 | $4 | $8 |
| Hospital follow-up visit, low complexity | 37 | $40 | $68 |
| Ct scan of abdomen and pelvis before and after contrast | 31 | $263 | $1,077 |
| Red blood count, automated test | 27 | $4 | $8 |
| New patient office visit, complex (60-74 min) | 26 | $149 | $421 |
| Initial hospital admission, high complexity | 26 | $135 | $414 |
| Basic metabolic blood panel | 20 | $8 | $17 |
| Urine culture, bacterial identification | 20 | $8 | $34 |
| Ct scan of chest with contrast | 17 | $96 | $576 |
| Complete x-ray of body bones | 17 | $72 | $280 |
| Magnesium level test | 17 | $7 | $13 |
| Chest X-ray, 2 views | 15 | $22 | $96 |
| Testosterone (hormone) level, total | 14 | $25 | $52 |
| CT scan of abdomen and pelvis with contrast | 11 | $238 | $959 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.1% high complexity
22.5% medium
4.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,369
Total received (2018-2024)
Avg $1,395/year across 6 years
Top 39% in FL for hematology & oncology
53
Companies
300
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,414 (88.6%)
Other
Charitable contributions, space rental, and other categories
$632 (7.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$323 (3.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,838
2023$2,537
2022$1,892
2021$47
2019$35
2018$19
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
US Oncology Corporate, Inc.
$1,383
Novartis Pharmaceuticals Corporation
$869
PFIZER INC.
$685
Daiichi Sankyo Inc.
$452
Merck Sharp & Dohme LLC
$430
Incyte Corporation
$363
Lilly USA, LLC
$314
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Gilead Sciences, Inc.
$277
Celgene Corporation
$270
AstraZeneca Pharmaceuticals LP
$248
Janssen Biotech, Inc.
$232
Kite Pharma, Inc.
$218
Bayer Healthcare Pharmaceuticals Inc.
$171
Genentech USA, Inc.
$164
ABBVIE INC.
$145
E.R. Squibb & Sons, L.L.C.
$135
GENZYME CORPORATION
$131
Astellas Pharma US Inc
$131
Aveo Pharmaceuticals, Inc.
$123
Seagen Inc.
$104
GlaxoSmithKline, LLC.
$93
Blueprint Medicines Corporation
$82
Mylan Institutional Inc.
$81
SOBI, INC
$77
Pharmacosmos Therapeutics Inc.
$64
AVEO Pharmaceuticals, Inc.
$61
TAIHO ONCOLOGY, INC.
$58
Rigel Pharmaceuticals, Inc.
$54
Takeda Pharmaceuticals U.S.A., Inc.
$49
Global Blood Therapeutics, Inc.
$47
Ipsen Biopharmaceuticals, Inc
$41
PUMA BIOTECHNOLOGY, INC.
$38
Biocompatibles, Inc.
$35
Regeneron Healthcare Solutions, Inc.
$34
Amgen Inc.
$33
CTI BioPharma Corp.
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
Verity Pharmaceuticals Inc.
$30
Fennec Pharmaceuticals, Inc.
$25
Dendreon Pharmaceuticals LLC
$25
Eisai Inc.
$24
Alexion Pharmaceuticals, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
Deciphera Pharmaceuticals Inc.
$23
Sobi, Inc
$21
Boston Scientific Corporation
$20
Agios Pharmaceuticals, Inc.
$20
Kyowa Kirin, Inc.
$18
Merck Sharp & Dohme Corporation
$17
Foundation Medicine, Inc.
$17
MACROGENICS, INC.
$14
Puma Biotechnology, Inc.
$13
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · BOSULIF · CABLIVI · CALQUENCE · CYRAMZA · Columvi · DOPTELET · Doptelet · ELIQUIS · ENHERTU · ERLEADA · Enhertu · FOTIVDA · FOUNDATIONONE · Fabhalta · IBRANCE · INJECTAFER · INLYTA · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONOFERRIC · NERLYNX · NINLARO · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Ogivri · Onivyde · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · PYRUKYND · Pedmark · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · SARCLISA · SCEMBLIX · SHINGRIX · Somatuline Depot · Stivarga · TASIGNA · TECVAYLI · THERASPHERE-BIO · Tavalisse · Tecentriq · Trelstar · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vonjo · XTANDI · Xtandi · Yescarta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (89%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
14
Per 100K population
1.8
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. El-Far is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. El-Far experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. El-Far performed 156,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. El-Far receive payments from pharmaceutical companies?
Yes. Dr. El-Far received a total of $8,369 from 53 companies across 300 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. El-Far's costs compare to other hematology & oncologys in Winter Haven?
Dr. El-Far's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. El-Far) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Winter Haven
Browse hematology & oncologys in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology